» Articles » PMID: 31305532

Measuring Relative Insulin Secretion Using a Co-Secreted Luciferase Surrogate

Overview
Journal J Vis Exp
Date 2019 Jul 16
PMID 31305532
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Performing antibody-based assays for secreted insulin post-sample collection usually requires a few hours to a day of assay time and can be expensive, depending on the specific assay. Secreted luciferase assays expedite results and lower the assay cost per sample substantially. Here we present a relatively underused approach to gauge insulin secretory activity from pancreatic β cells by using Gaussia luciferase genetically inserted within the C-peptide. During proteolytic processing of proinsulin, the C-peptide is excised releasing the luciferase within the insulin secretory vesicle where it is co-secreted with insulin. Results can be obtained within minutes after sample collection because of the speed of luciferase assays. A limitation of the assay is that it is a relative measurement of insulin secretion and not an absolute quantitation. However, this protocol is economical, scalable, and can be performed using most standard luminescence plate readers. Analog and digital multichannel pipettes facilitate multiple steps of the assay. Many different experimental variations can be tested simultaneously. Once a focused set of conditions are decided upon, insulin concentrations should be measured directly using antibody-based assays with standard curves to confirm the luciferase assay results.

Citing Articles

Rapid Quantification of First and Second Phase Insulin Secretion Dynamics using an In vitro Platform for Improving Insulin Therapy.

Thoduvayil S, Weerakkody J, Sundaram R, Topper M, Bera M, Coleman J Cell Calcium. 2023; 113:102766.

PMID: 37295201 PMC: 10450995. DOI: 10.1016/j.ceca.2023.102766.


A High-Content Screen for the Identification of Plant Extracts with Insulin Secretion-Modulating Activity.

Hager R, Pitsch J, Kerbl-Knapp J, Neuhauser C, Ollinger N, Iken M Pharmaceuticals (Basel). 2021; 14(8).

PMID: 34451906 PMC: 8402219. DOI: 10.3390/ph14080809.


High-Throughput Screening for Insulin Secretion Modulators.

Kalwat M Methods Mol Biol. 2020; 2233:131-138.

PMID: 33222132 PMC: 8812827. DOI: 10.1007/978-1-0716-1044-2_9.

References
1.
Mourad N, Nenquin M, Henquin J . Amplification of insulin secretion by acetylcholine or phorbol ester is independent of β-cell microfilaments and distinct from metabolic amplification. Mol Cell Endocrinol. 2012; 367(1-2):11-20. DOI: 10.1016/j.mce.2012.12.002. View

2.
Frank J, Broichhagen J, Yushchenko D, Trauner D, Schultz C, Hodson D . Optical tools for understanding the complexity of β-cell signalling and insulin release. Nat Rev Endocrinol. 2018; 14(12):721-737. DOI: 10.1038/s41574-018-0105-2. View

3.
Hulleman J, Brown S, Rosen H, Kelly J . A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion. J Biomol Screen. 2012; 18(6):647-58. PMC: 4435789. DOI: 10.1177/1087057112469405. View

4.
Watkins S, Geng X, Li L, Papworth G, Robbins P, Drain P . Imaging secretory vesicles by fluorescent protein insertion in propeptide rather than mature secreted peptide. Traffic. 2002; 3(7):461-71. DOI: 10.1034/j.1600-0854.2002.30703.x. View

5.
Tannous B . Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc. 2009; 4(4):582-91. PMC: 2692611. DOI: 10.1038/nprot.2009.28. View